CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade BIO-key International, Inc. - BKYI CFD

2.0784
1.46%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.0232
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.001
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 2.0484
Open* 2.0484
1-Year Change* 181.88%
Day's Range* 2.0484 - 2.0884
52 wk Range 0.26-1.70
Average Volume (10 days) 30.71K
Average Volume (3 months) 600.31K
Market Cap 3.16M
P/E Ratio -100.00K
Shares Outstanding 9.26M
Revenue 8.14M
EPS -1.31
Dividend (Yield %) N/A
Beta 0.92
Next Earnings Date Nov 13, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 2.0784 0.0300 1.46% 2.0484 2.0884 2.0484
Mar 27, 2024 2.0484 0.1100 5.67% 1.9384 2.0984 1.8884
Mar 26, 2024 1.9584 0.0200 1.03% 1.9384 1.9984 1.9384
Mar 25, 2024 1.9984 0.1500 8.12% 1.8484 1.9984 1.8484
Mar 22, 2024 1.9984 0.1300 6.96% 1.8684 1.9984 1.8684
Mar 21, 2024 1.8784 -0.0100 -0.53% 1.8884 1.9584 1.8384
Mar 20, 2024 1.8984 -0.1100 -5.48% 2.0084 2.0084 1.7984
Mar 19, 2024 1.9684 0.0300 1.55% 1.9384 1.9984 1.9384
Mar 18, 2024 1.9784 0.0300 1.54% 1.9484 2.0884 1.9284
Mar 15, 2024 1.9684 0.1500 8.25% 1.8184 1.9884 1.8184
Mar 14, 2024 1.8984 -0.1100 -5.48% 2.0084 2.0184 1.7984
Mar 13, 2024 2.0184 -0.0100 -0.49% 2.0284 2.1084 1.9884
Mar 12, 2024 2.1684 0.1400 6.90% 2.0284 2.3984 1.9784
Mar 11, 2024 2.0284 0.0300 1.50% 1.9984 2.0784 1.9784
Mar 8, 2024 1.9784 0.0600 3.13% 1.9184 2.0284 1.9184
Mar 7, 2024 1.9984 0.0400 2.04% 1.9584 2.1084 1.9484
Mar 6, 2024 2.0284 0.2000 10.94% 1.8284 2.0984 1.8284
Mar 5, 2024 1.9684 -0.0600 -2.96% 2.0284 2.0584 1.8284
Mar 4, 2024 2.0284 -0.0800 -3.79% 2.1084 2.1584 1.9984
Mar 1, 2024 2.0884 0.0900 4.50% 1.9984 2.1184 1.9984

BIO-key International, Inc. Events

Time (UTC) Country Event
Tuesday, April 2, 2024

Time (UTC)

14:00

Country

US

Event

Q4 2023 BIO-Key International Inc Earnings Call
Q4 2023 BIO-Key International Inc Earnings Call

Forecast

-

Previous

-

Time (UTC)

20:00

Country

US

Event

Q4 2023 BIO-Key International Inc Earnings Release
Q4 2023 BIO-Key International Inc Earnings Release

Forecast

-

Previous

-
Monday, May 13, 2024

Time (UTC)

20:00

Country

US

Event

Q1 2024 BIO-Key International Inc Earnings Release
Q1 2024 BIO-Key International Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 7.02026 5.11449 2.83678 2.26753 4.04454
Revenue 7.02026 5.11449 2.83678 2.26753 4.04454
Cost of Revenue, Total 2.43957 1.67293 0.79483 2.46125 4.16419
Gross Profit 4.58069 3.44156 2.04195 -0.19372 -0.11965
Total Operating Expense 17.4439 10.0563 8.53903 15.7872 10.9135
Selling/General/Admin. Expenses, Total 9.36489 6.02836 5.84869 5.03682 5.33391
Research & Development 3.25224 2.35506 1.39644 1.33167 1.4154
Operating Income -10.4236 -4.94186 -5.70225 -13.5197 -6.86896
Interest Income (Expense), Net Non-Operating -0.85925 -0.12393 -4.31256 -1.06898 0.00008
Net Income Before Taxes -11.9303 -5.06578 -9.67399 -14.5887 -6.86888
Net Income After Taxes -11.9099 -5.06578 -9.67399 -14.5887 -6.86888
Net Income Before Extra. Items -11.9099 -5.06578 -9.67399 -14.5887 -6.86888
Net Income -11.9099 -5.06578 -9.67399 -14.5887 -6.86888
Total Adjustments to Net Income 0 -0.11269 0 -1.627
Income Available to Common Excl. Extra. Items -11.9099 -5.06578 -9.78667 -14.5887 -8.49587
Income Available to Common Incl. Extra. Items -11.9099 -5.06578 -9.78667 -14.5887 -8.49587
Diluted Net Income -11.9099 -5.06578 -9.78667 -14.5887 -8.49587
Diluted Weighted Average Shares 8.10079 7.79174 4.70079 1.77796 1.45099
Diluted EPS Excluding Extraordinary Items -1.47022 -0.65015 -2.08192 -8.2053 -5.85522
Diluted Normalized EPS -1.27867 -0.65015 -1.97575 -4.2921 -5.85522
Unusual Expense (Income) 2.38719 0 0.49908 6.95752
Other, Net -0.64746 0 0.34082
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 1.82837 1.92893 3.08377 1.75842 1.37355
Revenue 1.82837 1.92893 3.08377 1.75842 1.37355
Cost of Revenue, Total 0.4266 0.60611 0.82027 0.98439 0.39378
Gross Profit 1.40177 1.32282 2.2635 0.77403 0.97977
Total Operating Expense 2.5777 3.10746 3.44217 7.25458 3.734
Selling/General/Admin. Expenses, Total 1.59241 1.94316 1.93173 3.04961 2.51071
Research & Development 0.55869 0.55818 0.69016 0.83338 0.82951
Unusual Expense (Income) 2.38719
Operating Income -0.74933 -1.17853 -0.3584 -5.49616 -2.36045
Interest Income (Expense), Net Non-Operating 0.06223 -0.10136 0.07008 -0.66586 -0.04206
Net Income Before Taxes -0.68709 -1.27988 -0.28832 -6.80947 -2.40251
Net Income After Taxes -0.74909 -1.42288 -0.28832 -6.78903 -2.40251
Net Income Before Extra. Items -0.74909 -1.42288 -0.28832 -6.78903 -2.40251
Net Income -0.74909 -1.42288 -0.28832 -6.78903 -2.40251
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -0.74909 -1.42288 -0.28832 -6.78903 -2.40251
Income Available to Common Incl. Extra. Items -0.74909 -1.42288 -0.28832 -6.78903 -2.40251
Diluted Net Income -0.74909 -1.42288 -0.28832 -6.78903 -2.40251
Diluted Weighted Average Shares 9.1309 9.02143 8.94449 8.24052 8.14885
Diluted EPS Excluding Extraordinary Items -0.08204 -0.15772 -0.03223 -0.82386 -0.29483
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.08204 -0.15772 -0.03223 -0.63556 -0.29483
Other, Net -0.64746
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 8.98488 14.0129 18.9419 1.36629 4.2293
Cash and Short Term Investments 2.63552 7.75405 17.5059 0.59183 0.32394
Cash & Equivalents 2.63552 7.75405 16.9931 0.07901 0.32394
Total Receivables, Net 1.57228 1.10213 0.9035 0.23694 1.63071
Accounts Receivable - Trade, Net 1.52278 0.97063 0.54805 0.126 1.57403
Total Inventory 4.43437 4.94066 0.33095 0.42912 0.99883
Prepaid Expenses 0.34271 0.21604 0.20151 0.1084 0.15081
Other Current Assets, Total 0 1.125
Total Assets 11.3443 17.769 22.5206 2.4967 11.6923
Property/Plant/Equipment, Total - Net 0.30477 0.32327 0.56912 0.66199 0.14861
Intangibles, Net 1.76283 1.34683 1.57303 0.22819 6.98652
Note Receivable - Long Term 0.113 0
Other Long Term Assets, Total 0.29178 0.25772 0.17403 0.24023 0.32791
Total Current Liabilities 5.45569 1.99931 1.8763 4.39141 1.22611
Accounts Payable 1.10828 0.42777 0.24416 0.91929 0.48127
Accrued Expenses 1.16879 1.00619 0.7428 0.85745 0.54823
Notes Payable/Short Term Debt 2.5962 0 0.232 2.25545 0
Other Current Liabilities, Total 0.46242 0.56536 0.65735 0.35921 0.19661
Total Liabilities 6.0427 2.15359 2.18545 4.78187 1.22611
Total Long Term Debt 0.32677 0 0 0 0
Total Equity 5.30156 15.6155 20.3351 -2.28517 10.4662
Redeemable Preferred Stock 0
Preferred Stock - Non Redeemable, Net 0
Common Stock 0.00092 0.00079 0.00078 0.00144 0.0014
Additional Paid-In Capital 122.029 120.19 119.844 87.4364 85.5991
Retained Earnings (Accumulated Deficit) -116.485 -104.575 -99.5097 -89.723 -75.1343
Total Liabilities & Shareholders’ Equity 11.3443 17.769 22.5206 2.4967 11.6923
Total Common Shares Outstanding 9.1905 7.85376 7.81457 1.80143 1.74723
Total Preferred Shares Outstanding 0
Short Term Investments 0 0.51282 0.51282
Property/Plant/Equipment, Total - Gross 1.33244 1.30714 1.49834 1.43429
Accumulated Depreciation, Total -1.02767 -0.98388 -0.92923 -0.7723
Other Liabilities, Total 0.08996 0.15427 0.30915 0.39047
Goodwill, Net 1.26253 1.26253
Long Term Investments 0.45282
Current Port. of LT Debt/Capital Leases 0.12
Long Term Debt 0.32677
Deferred Income Tax 0.17028
Other Equity, Total -0.2426
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 7.92034 8.53133 8.93608 8.98488 9.88255
Cash and Short Term Investments 0.30709 0.56551 0.72234 2.63552 2.77462
Cash & Equivalents 0.30709 0.56551 0.72234 2.63552 2.77462
Short Term Investments
Total Receivables, Net 2.96179 3.25304 3.4447 1.57228 1.85754
Accounts Receivable - Trade, Net 2.89922 3.17879 3.3622 1.52278 1.80804
Total Inventory 4.28921 4.3841 4.42782 4.43437 4.89267
Prepaid Expenses 0.36225 0.32868 0.34123 0.34271 0.35773
Total Assets 9.83266 10.5833 11.1061 11.3443 15.026
Property/Plant/Equipment, Total - Net 0.11967 0.16566 0.22539 0.30477 0.3892
Goodwill, Net 2.1977
Intangibles, Net 1.51959 1.60009 1.68159 1.76283 1.84036
Note Receivable - Long Term 0.146
Other Long Term Assets, Total 0.27306 0.28616 0.26299 0.29178 0.30739
Total Current Liabilities 6.08977 6.27609 5.42539 5.45569 3.34357
Accounts Payable 1.6441 1.85599 1.21007 1.10828 1.06857
Accrued Expenses 1.07221 0.9783 0.97287 1.16879 1.05418
Notes Payable/Short Term Debt 2.41289 2.49878 2.45421 2.5962 0
Other Current Liabilities, Total 0.82526 0.80771 0.65334 0.46242 1.10082
Total Liabilities 6.50524 6.73815 5.9493 6.0427 3.8275
Total Long Term Debt 0.22163 0.25522 0.27758 0.32677 0.32187
Other Liabilities, Total 0.04685 0.04685 0.07334 0.08996 0.16206
Total Equity 3.32742 3.84509 5.15676 5.30156 11.1985
Common Stock 0.00095 0.00093 0.00092 0.00092 0.00085
Additional Paid-In Capital 122.362 122.191 122.1 122.029 121.123
Retained Earnings (Accumulated Deficit) -118.92 -118.197 -116.774 -116.485 -109.696
Total Liabilities & Shareholders’ Equity 9.83266 10.5833 11.1061 11.3443 15.026
Total Common Shares Outstanding 9.43889 9.26285 9.22606 9.1905 8.45262
Long Term Investments 0.26282
Current Port. of LT Debt/Capital Leases 0.13531 0.13531 0.1349 0.12 0.12
Long Term Debt 0.22163 0.25522 0.27758 0.32677 0.32187
Other Equity, Total -0.11521 -0.15057 -0.17046 -0.2426 -0.22935
Deferred Income Tax 0.147 0.16 0.173 0.17028
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -11.9099 -5.06578 -9.67399 -14.5887 -6.86888
Cash From Operating Activities -6.22903 -8.97843 -4.95011 -1.85035 -1.61348
Cash From Operating Activities 0.04379 0.05465 0.08575 0.08185 0.08462
Amortization 0.34687 0.2262 0.12024 0.88654 1.52883
Non-Cash Items 5.60967 1.08662 5.89771 9.64105 2.96836
Cash Interest Paid 0.01046 0.018 0.10943 0.07282 0
Changes in Working Capital -0.29902 -5.28012 -1.37982 2.12891 0.67359
Cash From Investing Activities -0.69662 -0.04202 -2.22982 -0.54331 -0.08246
Capital Expenditures -0.08204 -0.04202 -0.03557 -0.02875 -0.05206
Cash From Financing Activities 1.90324 -0.2186 24.094 2.14873 1.73116
Financing Cash Flow Items -0.00523 -2.69302 -0.36127 -0.14395
Total Cash Dividends Paid
Issuance (Retirement) of Stock, Net 0.05638 0.03663 27.777 0 1.8751
Issuance (Retirement) of Debt, Net 1.84686 -0.25 -0.98999 2.51
Net Change in Cash -5.11852 -9.23905 16.9141 -0.24493 0.03522
Other Investing Cash Flow Items, Total -0.61458 0 -2.19425 -0.51456 -0.0304
Cash Taxes Paid 0.02568 0 0 0 0
Deferred Taxes -0.02043
Foreign Exchange Effects -0.09611
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -11.9099 -5.12087 -2.71836 -0.9994
Cash From Operating Activities -6.22903 -4.3284 -2.28745 -1.43438
Cash From Operating Activities 0.04379 0.03381 0.02178 0.01122
Amortization 0.34687 0.21681 0.1064 0.05423
Non-Cash Items 5.60967 0.82218 0.47376 0.22205
Cash Interest Paid 0.01046 0.00366 0.00154 0
Changes in Working Capital -0.29902 -0.28033 -0.17103 -0.72248
Cash From Investing Activities -0.69662 -0.52652 -0.52034 -0.54504
Capital Expenditures -0.08204 -0.03107 -0.02289 -0.00446
Cash From Financing Activities 1.90324 0 0 0
Financing Cash Flow Items 0 0 0
Issuance (Retirement) of Stock, Net 0.05638
Issuance (Retirement) of Debt, Net 1.84686 0 0 0
Net Change in Cash -5.11852 -4.97943 -2.861 -1.95293
Other Investing Cash Flow Items, Total -0.61458 -0.49545 -0.49745 -0.54058
Cash Taxes Paid 0.02568
Foreign Exchange Effects -0.09611 -0.12451 -0.05322 0.02649
Deferred Taxes -0.02043

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

BIO-key International, Inc. Company profile

About BIO-key International, Inc.

BIO-key International, Inc. is an identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers. The Company's products include PortalGuard and PortalGuard identity-as-a-service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, and accessory hardware to customers. PortalGuard IDaaS offers flexible single sign-on and authentication options to meet users' security goals and deliver an optimized user experience. WEB-key is a scalable biometric service management platform, incorporating key functions for regulatory compliance, enrollment, authentication or identification, and integrity in a multi-tenant private or public cloud delivery platform. It also offers biometric software integration application programming interfaces (APIs), allowing software developers to leverage its platform to securely embed biometric multi-factor authentication (MFA), into their own products.

Financial summary

BRIEF: For the nine months ended 30 September 2021, BIO-key International, Inc. revenues increased from $1.8M to $4.2M. Net loss applicable to common stockholders decreased 64% to $3M. Revenues reflect License fees increase from $605K to $2M, Hardware increase from $239K to $1.2M, Services increase of 6% to $985K. Lower net loss reflects Interest expense decrease of 100% to $18K (expense), Loss on extinguishment of debt decrease from $499K (expense) to

Equity composition

Common Stock $.0001 Par, 03/11, 170M auth., 78,155,413 issd. Insiders control 0.49%. IPO: 2/97,2,420,000 shares @ $3 by Tuschner & Company, Inc. 7/97, 2-for-1 stock split. Series A Convertible Preferred Stock $.0001 Par, 100K auth., 30,557 issd. Series D Convertible Preferred Stock $.0001 Par, 02/15, 1-for-2 reverse stock split.

Industry: Biometric Products

101 Crawfords Corner Rd
Suite 4116
HOLMDEL
NEW JERSEY 07733
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

BTC/USD

69,672.85 Price
-1.140% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,508.94 Price
-0.870% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading